Research graph
References from The eyes and Parkinsonian syndromes. Local targets link to admitted publications; unresolved targets remain external evidence.
Detecting abnormal eye movements in patients with neurodegenerative diseases – current insights
10.2147/eb.s384769 · 2024 · External reference
Visual dysfunction in Parkinson's disease
10.1016/bs.irn.2017.04.007 · 2017 · External reference
New perspectives on the pathophysiology of Parkinson's disease as assessed by saccade performance: a clinical review
10.1016/j.clinph.2013.01.021 · 2013 · External reference
Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes
10.1002/ana.410390314 · 1996 · External reference
Differentiating early Parkinson's disease and multiple system atrophy with parkinsonism by saccade velocity profiles
10.1016/j.clinph.2019.09.004 · 2019 · External reference
Smooth pursuit and memory saccades are impaired in early-stage Parkinson's disease patients
10.3389/fneur.2025.1702050 · 2025 · External reference
Eye movements in Parkinson's disease and inherited Parkinsonian syndromes
10.3389/fneur.2017.00592 · 2017 · External reference
Unresolved reference
2021 · External reference
Prevalence of convergence insufficiency-type symptomatology in Parkinson's disease
10.1017/cjn.2017.39 · 2017 · External reference
Prevalence of convergence insufficiency in Parkinson's disease
10.1002/mdc3.12453 · 2017 · External reference
Ophthalmologic features of Parkinson's disease
10.1212/01.wnl.0000103444.45882.d8 · 2004 · External reference
Convergence insufficiency and Parkinson's disease progression
10.1016/j.parkreldis.2025.107341 · 2025 · External reference
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
10.1016/s1474-4422(17)30157-6 · 2017 · External reference
Progressive supranuclear palsy. a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia
10.1001/archneur.1964.00460160003001 · 1964 · External reference
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges
10.1016/s1474-4422(09)70042-0 · 2009 · External reference
The “round the houses” sign in progressive supranuclear palsy
10.1002/ana.410400630 · 1996 · External reference
Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy
10.1007/s00415-020-10230-w · 2021 · External reference
Optical coherence tomography measurements as potential imaging biomarkers for Parkinson's disease: a systematic review and meta-analysis
10.1111/ene.14613 · 2021 · External reference
The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis
10.3389/fneur.2010.00147 · 2010 · External reference
Ocular motor dysfunction in patients with multiple system atrophy and Parkinson's disease
10.1016/j.clinph.2025.2111413 · 2026 · External reference
Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients
10.1002/mds.21999 · 2008 · External reference
Central nystagmus in progressive supranuclear palsy: a neglected clinical feature?
10.1016/j.parkreldis.2021.01.003 · 2021 · External reference
Perverted head-shaking and positional downbeat nystagmus in patients with multiple system atrophy
10.1002/mds.22559 · 2009 · External reference
Spread deficits in initiation, speed and accuracy of horizontal and vertical automatic saccades in dementia with lewy bodies
10.3389/fneur.2010.00138 · 2010 · External reference
Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies
10.1093/brain/awh484 · 2005 · External reference
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers
10.1212/01.wnl.0000256715.13907.d3 · 2007 · External reference
Visual involvement in corticobasal syndrome
10.1097/wno.0b013e3182305162 · 2012 · External reference
Corticobasal degeneration
10.1016/s1474-4422(04)00936-6 · 2004 · External reference
Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy
10.1212/wnl.54.5.1029 · 2000 · External reference
Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease
10.1093/brain/awn047 · 2008 · External reference
Prevalence of blepharospasm and apraxia of eyelid opening in patients with parkinsonism, cervical dystonia and essential tremor
10.1159/000341621 · 2012 · External reference
Eyelid dysfunction in neurodegenerative, neurogenetic, and neurometabolic disease
10.3389/fneur.2017.00329 · 2017 · External reference
Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study
10.1212/01.wnl.0000052991.70149.68 · 2003 · External reference
Prevalence and characteristics of dry eye disease in Parkinson's disease: a systematic review and meta-analysis
10.1038/s41598-022-22037-y · 2022 · External reference
Automatic analysis of eyelid movement in de-novo Parkinson's disease
10.1038/s41531-025-01021-z · 2025 · External reference
Facial bradykinesia
10.1136/jnnp-2012-303993 · 2013 · External reference
Ocular features of multiple system atrophy
10.1016/j.jocn.2017.10.028 · 2018 · External reference
Autonomic dysfunction in different subtypes of multiple system atrophy
10.1002/mds.22187 · 2008 · External reference
Corneal sensitivity, blink rate, and corneal nerve density in progressive supranuclear palsy and Parkinson disease
10.1097/ico.0b013e3182574ade · 2013 · External reference
Visual dysfunction in dementia with Lewy bodies
10.1007/s11910-024-01349-8 · 2024 · External reference
Lewy body dementias
10.1016/s0140-6736(15)00462-6 · 2015 · External reference
The neuropsychiatry of Parkinson's disease: advances and challenges
10.1016/s1474-4422(21)00330-6 · 2022 · External reference
Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromes
10.1093/brain/awaf132 · 2025 · External reference
Visuospatial functions in atypical Parkinsonian syndromes
10.1136/jnnp.2005.068239 · 2006 · External reference
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
10.1016/s1474-4422(09)70068-7 · 2009 · External reference
Reduced maximal range of ocular movements and its response to acute levodopa challenge in Parkinson's disease
10.3389/fnagi.2024.1368539 · 2024 · External reference
Effects of STN stimulation on the initiation and inhibition of saccade in Parkinson disease
10.1212/wnl.0b013e3181d31e0b · 2010 · External reference
Visual hallucinations and the role of medications in Parkinson's disease: triggers, pathophysiology, and management
10.1176/appi.neuropsych.19110316 · 2020 · External reference
Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease
10.1016/s1474-4422(08)70291-6 · 2009 · External reference
Surgical complications in patients with Parkinson's disease after posteroventral pallidotomy
10.1227/01.neu.0000047817.60776.5c · 2003 · External reference
Visual fields in patients with posterior GPi pallidotomy
10.1212/wnl.50.1.258 · 1998 · External reference
Pallidotomy for Parkinson disease: a review of contemporary literature
10.3171/jns.2001.94.1.0043 · 2001 · External reference
Trial of globus pallidus focused ultrasound ablation in Parkinson's disease
10.1056/nejmoa2202721 · 2023 · External reference
Undetected ophthalmological disorders in Parkinson's disease
10.1007/s00415-022-11014-0 · 2022 · External reference
New evidence on the management of Lewy body dementia
10.1016/s1474-4422(19)30153-x · 2020 · External reference
Retina thickness in atypical parkinsonism: a systematic review and meta-analysis
10.1007/s00415-021-10703-6 · 2022 · External reference
Retinal optical coherence tomography features associated with incident and prevalent Parkinson disease
10.1212/wnl.0000000000207727 · 2023 · External reference
Spectral domain and angiography optical coherence tomography in atypical parkinsonisms and Parkinson disease: an explorative study
10.1016/j.parkreldis.2025.107932 · 2025 · External reference
Advances in ocular motor and pupil biomarkers for neurological disorders
10.1093/braincomms/fcag102 · 2026 · External reference
Differentiating progressive supranuclear palsy and Parkinson's disease with head-mounted displays
10.3389/fneur.2021.791366 · 2021 · External reference
Classification and staging of Parkinson's disease using video-based eye tracking
10.1016/j.parkreldis.2023.105316 · 2023 · External reference
Follow-up observation of eye movements in multiple system atrophy and Parkinson's disease: a cohort study
10.1136/bmjopen-2024-094106 · 2025 · External reference
Elevated alpha-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease
10.1007/s11357-022-00576-6 · 2022 · External reference
Tear alpha-synuclein as a biomarker for Parkinson's disease: a systematic review and meta-analysis
10.1097/opx.0000000000002168 · 2024 · External reference
An exploratory analysis of differential tear fluid miRNAs in patients with Parkinson's disease and atypical parkinsonian syndromes
10.1007/s12035-025-05252-2 · 2025 · External reference
